PCN52 HEALTH CARE COSTS ASSOCIATED WITH MULTIKINASE INHIBITORS (MKIS) FOR TREATMENT OF METASTATIC RENAL CELL CARCINOMA (MRCC) IN A CLINICAL PRACTICE SETTING IN ITALY
May 1, 2010, 00:00
10.1016/S1098-3015(10)72141-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)72141-0/fulltext
Title :
PCN52 HEALTH CARE COSTS ASSOCIATED WITH MULTIKINASE INHIBITORS (MKIS) FOR TREATMENT OF METASTATIC RENAL CELL CARCINOMA (MRCC) IN A CLINICAL PRACTICE SETTING IN ITALY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72141-0&doi=10.1016/S1098-3015(10)72141-0
First page :
Section Title :
Open access? :
No
Section Order :
724